论文部分内容阅读
我们从节约社会宏观投入和提高筛查质量研究，用反正法６年应用检测ＥＢ病毒抗体的血清学方法随机对一定人群进行鼻咽癌血清学筛查，结果检出鼻咽癌早诊率４０．０％，表明仍以４～５年筛查一次为好。在筛查时我们还随机配对与抗体阳性者等量的阴性者同时进行临床鼻咽部检查，在阳性者中检出鼻咽癌５例，阴性未检查出癌，通过两者病理组织学比较，我们认为在应用血清学方法进行人群鼻咽癌筛查时随机配对与抗体阳性等量的抗体阴性者同时进行临床鼻咽部检查，可以作为评估筛查是否会漏诊和质控一种方法。
We save the community from the macro-investment and improve the quality of screening studies, using any method for 6 years, the application of detection of Epstein-Barr virus serological methods of randomized certain population serological screening of nasopharyngeal carcinoma, the results detected nasopharyngeal carcinoma 40 .0%, indicating that still 4 to 5 years screening once as well. In the screening we also randomly paired with the antibody-positive patients with the same amount of negative nasopharyngeal examination at the same time, positive in the detection of nasopharyngeal carcinoma in 5 cases, negative did not detect cancer by histopathological comparison We consider that simultaneous nasopharyngeal screening with serodiagnostic methods for nasopharyngeal cancer screening should be used as a method of assessing screening for misdiagnosis and quality control.